We previously showed in PN-fed neonatal pigs a disruption of bile acid-mediated activation of intestinal FXR-FGF19 signaling and that replacement with enteral CDCA restored FGF19 secretion and reduced serum markers of cholestasis 14. The gene discussed is FGF19; the disease is cholestasis.